Noriko Okudaira

945 citations

25 papers · 753 indexed · h-index 16

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Hepatotoxicity and Protection 3
Oncology top 10%
- Drug Transport and Resistance Mechanisms 12
Pediatrics, Perinatology and Child Health top 5%
- Pharmacological Effects and Toxicity Studies 7
Transplantation
Internal Medicine
Computational Theory and Mathematics
- Computational Drug Discovery Methods 3
Clinical Biochemistry
- Metabolism and Genetic Disorders 3
Gastroenterology
- Gastroesophageal reflux and treatments 2

Co-authors: Osamu Okazaki Takashi Izumi Atsushi Kurihara Tsuyoshi Mikkaichi Nobuyuki Murayama Tomoki Imaoka Hiroyuki Kusuhara Hiroaki Yuasa
Cited by: Pharmacology Oncology Pediatrics, Perinatology and Child Health
Journals: Journal of Pharmacology and Experimental Therapeutics (1 paper)International Journal of Pharmaceutics (1 paper)Biochemical Pharmacology (1 paper)
Partner nations: Japan Germany United States

In The Last Decade

Noriko Okudaira

24 papers receiving 731 citations

Peers

Countries citing papers authored by Noriko Okudaira

Since Specialization

Citations

This map shows the geographic impact of Noriko Okudaira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Okudaira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Okudaira more than expected).

Fields of papers citing papers by Noriko Okudaira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Okudaira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Okudaira. The network helps show where Noriko Okudaira may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Noriko Okudaira, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noriko Okudaira Line = papers co-authored together Noriko Okudaira links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A /P‐gp Modulators Clinical and Translational Science ·Akiko Watanabe,Noriko Okudaira,M Tachibana,Miho Kazui,Masakatsu Kotsuma,Takako Shimizu,Yvonne Lau	2025	0
2	Determination of Vatiquinone Drug‐Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation The Journal of Clinical Pharmacology ·Lucy Lee,Noriko Okudaira,Katsuyuki Murase,Ronald Kong,Hannah M. Jones	2024	2
3	Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study International Journal of Hematology ·Kensuke Usuki,Hiroshi Handa,Ilseung Choi,Takahiro Yamauchi,Hiroatsu Iida,Tomoko Hata,Shoichi Ohwada,Noriko Okudaira,Kota Nakamura,Sakura Sakajiri	2019	17
4	Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans Drug Metabolism and Pharmacokinetics ·Tsuyoshi Mikkaichi,Daisuke Nakai,Yasushi Yoshigae,Tomoki Imaoka,Noriko Okudaira,Takashi Izumi	2015	9
5	6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects Drug Metabolism and Disposition ·Yuichiro Imamura,Yuri Tsuruya,Katja Damme,Dominik Heer,Yuji Kumagai,Kazuya Maeda,Nobuyuki Murayama,Noriko Okudaira,Atsushi Kurihara,Takashi Izumi,Yuichi Sugiyama,Hiroyuki Kusuhara	2014	54
6	Edoxaban Transport via P-Glycoprotein Is a Key Factor for the Drug’s Disposition Drug Metabolism and Disposition ·Tsuyoshi Mikkaichi,Yasushi Yoshigae,Hiroshi Masumoto,Tomoki Imaoka,Veronika Rozehnal,Thomas M. Fischer,Noriko Okudaira,Takashi Izumi	2014	78
7	Integrated Approach of In Vivo and In Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats Using Rifampicin as an Inhibitor Drug Metabolism and Disposition ·Tomoki Imaoka,Tsuyoshi Mikkaichi,Kōji Abe,Masakazu Hirouchi,Noriko Okudaira,Takashi Izumi	2013	18
8	Effect of the Fluoroquinolone Antibacterial Agent DX-619 on the Apparent Formation and Renal Clearances of 6β-Hydroxycortisol, an Endogenous Probe for CYP3A4 Inhibition, in Healthy Subjects Pharmaceutical Research ·Yuichiro Imamura,Nobuyuki Murayama,Noriko Okudaira,Atsushi Kurihara,Katsuhisa Inoue,Hiroaki Yuasa,Takashi Izumi,Hiroyuki Kusuhara,Yuichi Sugiyama	2012	23
9	Prediction of Human Pharmacokinetics of Therapeutic Monoclonal Antibodies from Simple Allometry of Monkey Data Drug Metabolism and Pharmacokinetics ·Masataka Oitate,Noriko Masubuchi,Takashi Ito,Yoshiyuki Yabe,Tsuyoshi Karibe,Takanori Aoki,Nobuyuki Murayama,Atsushi Kurihara,Noriko Okudaira,Takashi Izumi	2011	60
10	Combination of GSH Trapping and Time-Dependent Inhibition Assays as a Predictive Method of Drugs Generating Highly Reactive Metabolites Drug Metabolism and Disposition ·Shintaro Nakayama,Hideo Takakusa,Akiko Watanabe,Yoshihiro Miyaji,Wataru Suzuki,Daisuke Sugiyama,Kazuhito Shiosakai,Kokichi Honda,Noriko Okudaira,Takashi Izumi,Osamu Okazaki	2011	25
11	Prediction of Human Plasma Concentration-time Profiles of Monoclonal Antibodies from Monkey Data by a Species-invariant Time Method Drug Metabolism and Pharmacokinetics ·Masataka Oitate,Shintaro Nakayama,Takashi Ito,Atsushi Kurihara,Noriko Okudaira,Takashi Izumi	2011	27
12	Prediction of Fluoroquinolone-Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion Clinical Pharmacology & Therapeutics ·Yoshinori Imamura,Nobuyuki Murayama,Noriko Okudaira,Atsushi Kurihara,Osamu Okazaki,Takashi Izumi,Katsuhisa Inoue,Hiroaki Yuasa,Hiroyuki Kusuhara,Yuichi Sugiyama	2010	86
13	Predictability of Idiosyncratic Drug Toxicity Risk for Carboxylic Acid-Containing Drugs Based on the Chemical Stability of Acyl Glucuronide Drug Metabolism and Disposition ·Ryoko Sawamura,Noriko Okudaira,Kengo Watanabe,Takahiro Murai,Yoshimasa Kobayashi,Masaya Tachibana,Toshihiko Ohnuki,Kayoko Masuda,Hidehito Honma,Atsushi Kurihara,Osamu Okazaki	2010	98
14	Effects of organic solvents on the time-dependent inhibition of CYP3A4 by diazepam Xenobiotica ·Yumi Nishiya,Kōichi Nakamura,Noriko Okudaira,Kumi Abe,B. R. Ko,Osamu Okazaki	2009	12
15	Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel Xenobiotica ·Yumi Nishiya,Katsunobu Hagihara,Atsushi Kurihara,Noriko Okudaira,Nazar Farid,Osamu Okazaki,T. Ikeda	2009	51
16	Functional Characterization of Multidrug and Toxin Extrusion Protein 1 as a Facilitative Transporter for Fluoroquinolones Journal of Pharmacology and Experimental Therapeutics ·Kinya Ohta,Yuichiro Imamura,Noriko Okudaira,Ryou Atsumi,Katsuhisa Inoue,Hiroaki Yuasa	2008	31
17	Risk Assessment for Drug-Drug Interaction Caused by Metabolism-Based Inhibition of CYP3A Using Automated in Vitro Assay Systems and Its Application in the Early Drug Discovery Process Drug Metabolism and Disposition ·Akiko Watanabe,Kōichi Nakamura,Noriko Okudaira,Osamu Okazaki,Kenichi Sudo	2007	53
18	Involvement of Multiple Transport Systems in the Disposition of an Active Metabolite of a Prodrugtype New Quinolone Antibiotic, Prulifloxacin Drug Metabolism and Pharmacokinetics ·Yukihiro Yagi,Sachiyo Shibutani,Naoko Hodoshima,Kazuya Ishiwata,Noriko Okudaira,Qing Li,Yoshimichi Sai,Yukio Kato,Akira Tsuji	2003	10
19	Up-Regulation of Carnitine Transporters Helps Maintain Tissue Carnitine Levels in Carnitine Deficiency Induced by Pivalic Acid Pharmaceutical Research ·Noriko Okudaira,Masao Fujigaki,Takemi Nakayoshi,Izumi Komiya,Yuichi Sugiyama	2001	7
20	FK 506 metabolism in male and female rat liver microsomes. Drug Metabolism and Disposition ·Beatrice Y. T. Perotti,Noriko Okudaira,Thomayant Prueksaritanont,Leslie Z. Benet	1994	15

About Noriko Okudaira

Noriko Okudaira is a scholar working on Pharmacology, Toxicology and Clinical Biochemistry, having authored 25 papers that have together received 753 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Computational Drug Discovery Methods (3 papers), Metabolism and Genetic Disorders (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Gastroesophageal reflux and treatments (2 papers). The work is most often cited by research in Pharmacology (292 citations), Oncology (346 citations) and Pediatrics, Perinatology and Child Health (205 citations). Noriko Okudaira has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Osamu Okazaki, Takashi Izumi, Atsushi Kurihara, Tsuyoshi Mikkaichi, Nobuyuki Murayama, Tomoki Imaoka, Hiroyuki Kusuhara, Hiroaki Yuasa, Yuichi Sugiyama and Katsuhisa Inoue. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact